Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients - Wikidata - awgldk - TriplyDB

Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients

Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients

http://www.wikidata.org/entity/Q34073891

about

Immunotherapy with myeloid cells for tolerance induction A systems model for immune cell interactions unravels the mechanism of inflammation in human skin.The cyclophilin-binding agent Sanglifehrin A is a dendritic cell chemokine and migration inhibitor Host-based Th2 cell therapy for prolongation of cardiac allograft viability.Mesenchymal stem cells for inducing tolerance in organ transplantation Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses.How tolerogenic dendritic cells induce regulatory T cells CD4(+)CD25(-)Nrp1(+) T cells synergize with rapamycin to prevent murine cardiac allorejection in immunocompetent recipients Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts.mTOR and metabolic regulation of conventional and regulatory T cells.Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells.The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells.Regulatory T cells for tolerance therapy: revisiting the concept.Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance Regulatory T cells exhibit decreased proliferation but enhanced suppression after pulsing with sirolimus.Bioinspired controlled release of CCL22 recruits regulatory T cells in vivo Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells.Sequential monitoring and stability of ex vivo-expanded autologous and nonautologous regulatory T cells following infusion in nonhuman primates.Controlled release formulations of IL-2, TGF-β1 and rapamycin for the induction of regulatory T cells.Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells.Combined administration of a mutant TGF-beta1/Fc and rapamycin promotes induction of regulatory T cells and islet allograft tolerance.Ex vivo-expanded cynomolgus macaque regulatory T cells are resistant to alemtuzumab-mediated cytotoxicity.Combining Theoretical and Experimental Techniques to Study Murine Heart Transplant Rejection.Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation.T regulatory cells and the control of alloimmunity: from characterisation to clinical application.Tolerogenic dendritic cells and their potential applications.Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells.Rejection and regulation: a tight balance.Translating tolerogenic therapies to the clinic - where do we stand?Promoting transplantation tolerance; adoptive regulatory T cell therapy.Transplant tolerance: new insights and strategies for long-term allograft acceptance.Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning.Potential and limitations of regulatory T-cell therapy in solid organ transplantation.Novel therapeutic and diagnostic management of heart transplant patients.Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells.Transplant trials with Tregs: perils and promises.Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells.A Novel mTORC1-Dependent, Akt-Independent Pathway Differentiates the Gut Tropism of Regulatory and Conventional CD4 T Cells.

P2860

Q27687406-11F640EE-CA0F-48CD-8A6D-C8F13D199037 Q33769731-5948B434-C732-468D-9C14-B6BED9CEF03B Q33869604-E6EC6AA3-F27D-4848-B0FE-87CE859A7CFE Q33895312-5A89E636-8A16-4D1F-8EE6-ABD15A64E0A7 Q34391029-F05CF32A-5C60-4EFC-A06C-E2093302F8DC Q34400439-F8DFC923-A1C8-4B4B-BFB4-E731A23A4ECD Q34565248-6AD5C5DD-A252-40DA-820E-1A0CC4E4C988 Q34631825-527D0B24-A8BF-4F90-B40D-5D56ABFDD7C9 Q34664134-1B436A5C-0A0C-4E0A-979C-86C6A531CC18 Q35044185-E50A967B-762C-4A62-B35D-2A1C8174255C Q35430711-9D554AA7-91A3-42CB-99A1-0C9A156CAA97 Q35514307-4EE6CA6B-14A7-43CD-BB8E-365C0FAE67F5 Q35608944-D02F7690-73BE-4132-A868-17CE3E1E33AB Q35621984-F75876A3-EEE6-4AC9-98AB-B4D699AAC117 Q35893430-A6B78BEF-73DC-4D83-B6E8-79B58770BACC Q36316613-8686B62E-56C9-40C1-8E52-082A5BD1E7AA Q36379675-F659B4E6-F6C7-4166-878C-871F939B0663 Q36408352-66C91D30-197B-47CA-A2E0-EA20962AFAB3 Q36420758-9C64496C-F75C-4092-8260-256703941FE4 Q36638732-DFA92492-7CC9-4A5D-921D-78DE712A2E43 Q36998551-8AFA60B6-3BF4-46FE-85E5-F450F76BB71B Q37112525-31298315-7128-427C-AD86-995F457774D9 Q37155930-2381390E-8FB9-4F24-B1FA-430D6984AABD Q37191195-3EF869DE-9B7D-498E-9432-CCB858EAD8B8 Q37396882-46BC3117-BED2-475E-BB0A-897E7AAA02EC Q37716661-A601B68D-B4C3-4E77-B319-8FC713FBAD31 Q37792312-FA0FAA6D-FD58-4070-90FD-B2270050880C Q37826217-24EE6CB4-FA50-4AA1-B45E-B02947243D4C Q37864694-100E4DF5-9469-461C-9436-EAD3523A5DF6 Q37966922-16886FF1-2CD5-402C-93B9-8E95FEA338D5 Q38039091-2DD59B76-9860-4B15-99D2-CA7572A479DD Q38097917-B70C225E-B5AD-451D-8EAB-991CC980131D Q38114067-D7430E20-C2B2-491F-A028-F5D31900160C Q38193165-FFF1491D-B335-467F-BCC1-50315C1BC40D Q38235166-1299F8A4-85FF-46C9-BA25-CA606E1559D4 Q38614686-CA237A7E-F353-4EF2-A62A-E26266AB183A Q39279238-9362493C-C884-4CC6-B6FB-F72D90226E75 Q39406891-F8EFB24F-8AFE-4367-A8AA-5930FC133AEF Q41208509-76762434-A41B-40E0-933C-526371F6E810 Q41891740-E2F59289-BAE2-4986-BA1E-C90324890E42

P2860

Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients

http://www.wikidata.org/entity/Q34073891

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Mammalian target of rapamycin ...... in immunocompetent recipients

@ast

Mammalian target of rapamycin ...... in immunocompetent recipients

@en

Mammalian target of rapamycin ...... in immunocompetent recipients

@nl

type

label

Mammalian target of rapamycin ...... in immunocompetent recipients

@ast

Mammalian target of rapamycin ...... in immunocompetent recipients

@en

Mammalian target of rapamycin ...... in immunocompetent recipients

@nl

prefLabel

Mammalian target of rapamycin ...... in immunocompetent recipients

@ast

Mammalian target of rapamycin ...... in immunocompetent recipients

@en

Mammalian target of rapamycin ...... in immunocompetent recipients

@nl

P1433

Q34073891-A778C0A3-D001-4DE6-AF1D-229F3BAA4770

P1476

Q34073891-1E793035-2798-4859-A566-B426AFFA0063

P2093

Q34073891-24FB1A98-497A-45EA-9F6A-80A3542B4E04

Q34073891-26937718-E342-46E9-96A0-685C7FBB9E51

Q34073891-494A0535-4DB7-4DD6-BAE7-CAAE8369D5D8

Q34073891-497F56B1-B0B2-4154-AC73-5471CCDBA295

Q34073891-A9DB6351-2F30-4C49-B9FA-31001904676D

Q34073891-C5111212-95A2-4D1F-99A4-B4FE27931A74

Q34073891-D249D620-12EB-46E2-942B-EDFC6D4C37F7

Q34073891-E0B92A74-33E0-4438-B66B-6D82BD2E7152

P2860

Q34073891-05B5A448-1AF6-481A-828F-666D99ABFAAB

Q34073891-063657A3-C138-44AB-8316-4CDD8225916A

Q34073891-0BEB056C-C876-4B25-B7A8-A0EA755503F3

Q34073891-13982645-01ED-4C4E-8030-809A86AE4F34

Q34073891-13B35F0D-AD50-4CEE-B93E-E7DE545C6A21

Q34073891-1CF34DF0-F2FD-4F72-91DC-33D766DABC58

Q34073891-1DE2CC5A-48FB-4F64-A107-F0D4AD2F5F1C

Q34073891-21F80C58-7EF6-40FB-AC67-902B91553E71

Q34073891-2E117ED7-2C9E-4C1B-B1E3-04DE7381D230

Q34073891-2E730837-6CE9-44FA-A85F-37406B431ECD

P304

Q34073891-A8B323C3-3619-4280-9C68-49AC2431BF69

P31

Q34073891-E9E5E45A-C705-426A-9EB7-55268F8215CA

P356

Q34073891-2B765857-1815-48B2-B823-C6CA5975A728

P407

Q34073891-AA4AA7F1-5A5E-4C7A-83E8-416B95095F38

P433

Q34073891-D2DD75D3-4FF1-4287-A67C-FC3BDA58B8E1

P478

Q34073891-47005E25-E488-48D4-A0B0-4D6E8674940A

P577

Q34073891-9FB1FDE8-931E-468E-A279-DA53BF34AA08

P5875

Q34073891-0DA9B1A2-CBF8-4BAD-8A0F-E10A9402FAED

P698

Q34073891-6A1A3685-A3FD-4050-A5C3-7DC295EF1E6A

P932

Q34073891-0A1831DB-CC71-4612-A165-4F503C6324D5

P356

JIMMUNOL.0900936

P1433

Journal of Immunology

P1476

Mammalian target of rapamycin ...... in immunocompetent recipients

@en

P2093

Angus W Thomson

http://www.w3.org/2001/XMLSchema#string

Benjamin M Matta

http://www.w3.org/2001/XMLSchema#string

Giorgio Raimondi

http://www.w3.org/2001/XMLSchema#string

Mahesh Pillai

http://www.w3.org/2001/XMLSchema#string

Natasha Corbitt

http://www.w3.org/2001/XMLSchema#string

Tina L Sumpter

http://www.w3.org/2001/XMLSchema#string

Yoram Vodovotz

http://www.w3.org/2001/XMLSchema#string

Zhiliang Wang

http://www.w3.org/2001/XMLSchema#string

P2860

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

Regulatory T cells and immune tolerance

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

IL-17 family cytokines and the expanding diversity of effector T cell lineages

Immunoregulatory functions of mTOR inhibition.

Role of LAG-3 in regulatory T cells.

Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction.

Identification of regulatory T cells in tolerated allografts.

Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes.

Antigen-specific peripheral shaping of the natural regulatory T cell population.

P304

624-636

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0900936

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

184

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40685287

http://www.w3.org/2001/XMLSchema#string

P698

20007530

http://www.w3.org/2001/XMLSchema#string

P932

2923839

http://www.w3.org/2001/XMLSchema#string